Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Infinity Pharmaceuticals, Inc. - Common Stock (NQ: INFI )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 13, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Infinity Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Earnings Scheduled For March 29, 2022
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million. 
Via Benzinga
Infinity Pharmaceuticals Earnings Preview
Infinity Pharmaceuticals (NASDAQ:INFI) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Infinity Pharmaceuticals Announces the Date of Its Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity Pharmaceuticals to Be Featured in a Fireside Chat as Part of B. Riley’s 2022 Virtual Oncology Conference
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity to Present at 40th Annual J.P. Morgan Healthcare Conference
From Infinity Pharmaceuticals, Inc.
Via Business Wire
50 Biggest Movers From Yesterday
Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is... 
Via Benzinga
Infinity Pharmaceuticals Outlines Eganelisib Clinical Development Strategy and Provides 2022 Guidance
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity Pharmaceuticals Added to the NASDAQ Biotechnology Index
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity Pharmaceuticals to be Featured in B. Riley Fireside Chat
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
Infinity Pharmaceuticals Inc (NASDAQ: INFI) presented updated data from the ongoing MARIO-3 study during the 2021 San Antonio Breast Cancer Symposium (SABCS).... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Reshape Lifesciences (NASDAQ:RSLS... 
Via Benzinga
Encouraging Updated Data from Phase 2 MARIO-3 TNBC Trial Presented at 2021 San Antonio Breast Cancer Symposium
From Infinity Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome... 
Via Benzinga
Infinity Pharmaceuticals to Host an Investor Event on Updated MARIO-3 Data Presented at the 2021 San Antonio Breast Cancer Symposium
From Infinity Pharmaceuticals, Inc.
Via Business Wire
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative... 
Via Benzinga
Exposures Product Safety
Infinity to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity Pharmaceuticals's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q2, Infinity Pharmaceuticals's (NASDAQ:INFI) reported sales totaled $512.00 thousand. Despite a 2.86% increase in earnings, the company... 
Via Benzinga
Infinity Announces the Date of Its Third Quarter 2021 Financial Results Conference Call and Webcast
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today
An analyst initiated coverage of the biotech stock with a unambiguous buy recommendation. 
Via The Motley Fool
Infinity to Participate in Oppenheimer’s Fall Healthcare Life Sciences and MedTech Summit and the 3rd Annual Macrophage-directed Therapies Summit
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity Pharmaceuticals Appoints Robert Ilaria, Jr., M.D., as Chief Medical Officer and Brian Schwartz, M.D., to Its Board of Directors
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences
From Infinity Pharmaceuticals, Inc.
Via Business Wire
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Arcturus Therapeutics (NASDAQ:ARCT) stock moved upwards by 29.05% to $44.73 during Tuesday's regular session. As of 12:35 EST, Arcturus Therapeutics's... 
Via Benzinga
Infinity Pharmaceuticals Reports Inducement Grants to Chief Scientific Officer under Nasdaq Listing Rule 5635(c)(4)
From Infinity Pharmaceuticals, Inc.
Via Business Wire
61 Biggest Movers From Yesterday
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company announced a $5 million stock repurchase program.... 
Via Benzinga
Why Infinity Pharmaceuticals Blasted 38% Higher Today
A big investment bank took a new and very bullish view on the stock. 
Via The Motley Fool
Mid-Afternoon Market Update: Nasdaq Gains 50 Points; Marin Software Shares Plummet
Toward the end of trading Monday, the Dow traded up 0.02% to 34,941.69 while the NASDAQ rose 0.37% to 14,727.42. The S&P also rose, gaining 0.10% to 4,399.45. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.